16:02 Dec 20
Kopran Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Kopran Ltd.
79/100 High Financial Strength
Quality63/100 Affordable Valuation
Valuation38/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
6
Opportunity
3
Threat
0
1.05K
Market Cap (Cr)
19.80
PE Ratio
2.11
Price to Book Ratio
42.07
RSI
8.29 %
Net Profit Margin
SWOT
Download Our App On:
